title: Anticoagulation techniques in apheresis: from heparin to citrate and beyond.
abstract: Anticoagulation is essential for maintaining the fluidity of extravascular blood on the apheresis circuit. Although both citrate and heparin are used as an anticoagulant during apheresis, citrate is preferred for the majority of exchange procedures because of its safety and effectiveness. Complications of citrate are primarily due to physiologic effects of hypocalcemia. Symptoms of hypocalcemia and other citrate-induced metabolic abnormalities affect neuromuscular and cardiac function and range in severity from mild dysesthesias (most common) to tetany, seizures, and cardiac arrhythmias. Oral or intravenous calcium supplementation is advised for decreased ionized calcium levels and/or symptomatic management of hypocalcemia. Heparin-based anticoagulation is limited to certain apheresis procedures (membrane-based plasma exchange, LDL apheresis, or photopheresis) or is used in combination with citrate to reduce citrate load. While effective, heparin anticoagulation is associated with an increased frequency of bleeding complications and heparin-induced thrombocytopenia. J. Clin. Apheresis 2012. © 2012 Wiley Periodicals, Inc.
authors.affiliation: Division of Hematology and Medical Oncology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Grace
authors.initials: G
authors.lastname: Lee
authors.forename: Gowthami M
authors.initials: GM
authors.lastname: Arepally
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001781:Blood Component Removal / Q000009:adverse effects / Q000379:methods*; D002118:Calcium / Q000008:administration & dosage; D019343:Citric Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006470:Hemorrhage / Q000209:etiology; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006996:Hypocalcemia / Q000188:drug therapy / Q000209:etiology; D012307:Risk Factors; D013921:Thrombocytopenia / Q000209:etiology
chemical_list: D000925:Anticoagulants; D019343:Citric Acid; D006493:Heparin; D002118:Calcium